{
  "trial_id": "NCT00126139",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age at least 18 years",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Presence of symptoms of an ischemic stroke with a baseline National Institutes of Health Stroke Scale (NIHSS) scale of one up to 20 or due to an ipsilateral atherosclerotic >50% stenosis of the extracranial internal carotid artery (ICA) as shown by ultrasonography.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Latency between the onset of stroke symptoms and intended administration of the study drugs is not more than 24 hours.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Latency between the intended administration of the study drugs and intended carotid endarterectomy is at least three days.",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Documented peptic ulcer disease within the preceding 30 days.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Septicemia or severe localized infection.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Severe illness (active cancer or significant liver or renal disease) or disability.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Alcohol or illicit drug abuse.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Pregnancy.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Need for chronic anticoagulant therapy (e.g. atrial fibrillation, deep venous thrombosis).",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Need for long-term daily nonsteroidal antiinflammatory drugs.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Contraindications for platelet therapy such as severe bleeding disorder within the past three months prior to randomization (coagulopathy, platelet disorder including history of heparin-induced thrombopenia, hemorrhage) or significant retinopathy with hemorrhages and exudates.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Hypersensitivity to abciximab, murine monoclonal antibodies or aspirin.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Any preexisting intracranial neurological disease such as tumor or multiple sclerosis.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Intracranial or intraspinal operation or trauma or lumbar puncture within the last 2 months.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Cardiac lesions likely to cause cardioembolism.",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "Patient has a history of CAD s/p CABG, EF 60% prior CVA (no residual deficits), HTN, HL, DMII, Moderate to Severe PVD. He reports occasional dizziness and no prior syncope or sensory/motor defects.",
  "_meta": {
    "topic_id": "5",
    "trial_id": "NCT00126139",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}